Click here to create your personal news page. The news that appears on Kidney Cancer will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Sony TA-DA6400ES
  2. 2. Yamaha RX-V3900
  3. 3. Mitac MiSTATION
  4. 4. Panasonic SC-H7
  5. 5. NEC MultiSync EA221WM
  6. 6. Liteon eSAU208
  7. 7. Toshiba 26AV550
  8. go to Shopping

Participate



Kidney Cancer


Sort by : relevance - date - popularity
+Vote!

Swallow this and you’ll get a better NHS

A 40-year-old mother of two young children with kidney cancer wants a new drug – it’s her only hope. The emergency room wants another triage nurse to reduce waiting times from four to two hours. And the ophthalmologists want to give two patients a new drug to prevent age-related blindness. Each intervention will cost £30,000. You only have £30,000 left – it’s your call.

+Vote!

Curate’s egg

This article is. Some very confused ideas about the costs of drugs: Kidney cancer drugs could be produced for about a tenth of their current cost, Rawlins said. While developing such medicines from scratch added to these costs, as did some ‘unnecessary’ bureaucracy around clinical trials which should be scrapped, he said that was not the [...]

+Vote!

Dorival Caymmi, Brazillian singer and songwriter, dies aged 94

Breitbart Brazilian singer and songwriter, has died today at the age of 94 at his Rio de Janeiro home. His death was caused by kidney cancer and multiple organ failures. Caymmi wrote over one hundred songs in … Read the full article here

+Vote!

Beyond PTEN: Alternate Genes Linked To Breast, Thyroid And Kidney Cancer Predisposition

A new discovery may lead to more effective screening and treatment for patients with a difficult to recognize syndrome characterized by tumor-like growths and a high risk of developing specific cancers. The research, published by Cell Press in the August 7 issue of the American Journal of Human Genetics, is the first in over thirteen [...]

+Vote!

NICE - just emotive price negotiations?

Pressure on pharmaceutical companies to lower the price of expensive cancer drugs was ramped up on Thursday after NICE, the UK's National Institute for Clinical Excellence, rejected four drugs that treat advanced kidney cancer. In an appraisal consultation document, NICE recommended against making Pfizer's Sutent, Roche's Avastin, Bayer's and Onyx's Nexavar and Wyeth's Torisel available on the NHS...

+Vote!

Letting patients down

It is ridiculous that in one of the world's wealthiest countries, kidney cancer patients seem likely, because of cost, to be denied effective drugs which would double thei

+Vote!

NHS denies 'effective' cancer drugs due to cost

Campaigners expressed outrage yesterday at a decision to deny four drug treatments to NHS patients with advanced kidney cancer.

+Vote!

Hard choice for NICE

Greed rules Only someone subhuman could fail to be moved by the plight of the kidney cancer patients who are denied drugs that could add months to their lives. Hard choices are unavoidable. The £30,000 per patient used could save...

1Vote!

Peter Johnson: Nice should re-evaluate its ruling on kidney cancer drugs

Peter Johnson: Today's judgment raises questions about how Nice evaluates drugs, particularly for cancers that affect a relatively small number of people

+Vote!

The price of health in England

Drugs that can keep cancer sufferers alive (bevacizumab, sorafenib, sunitinib and temsirolimus) are to be denied to patients because they do not represent value for money. link > Patients with advanced kidney cancer will be denied four treatments on the NHS under proposals from the government's drugs advisory body. The drugs - bevacizumab, sorafenib, sunitinib and temsirolimus - do not offer value...

+Vote!

Kidney cancer

A tumult has broken out over the funding of four drugs for advanced kidney cancer after the drugs advisory body NICE said they should not be use on the NHS. Andrew Crabb, from Abingdon in Oxfordshire, got the news on the first anniversary of his diagnosis with the disease - but says he will do everything he can to carry on receiving his drug. The 49-year-old former bricklayer, and his spouse Diane,...

+Vote!

Sorry, you will have to die, sooner rather than later?

Ok, so the headline may be emotive, but for many, many people that is the possible outcome of the recent decision of the National Institute for Health and Clinical Excellence (NICE), in saying new drugs that can extend life for those people who have advanced kidney cancer are simply too expensive to provide on the [...]

+Vote!

Watchdog says "no" to kidney cancer drugs

LONDON (Reuters) - Kidney cancer patients should not be treated with four expensive new medicines on the National Health Service, the country's health cost-effectiveness watchdog said on Thursday.

+Vote!

Drug decision 'bad for patients'

A cancer specialist criticises a recommendation that four drug treatments for kidney cancer remain unavailable on the NHS.

+Vote!

Cancer Patients Denied Treatment

Patients with advanced kidney cancer are to be denied four treatments on the NHS.